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Abstract
In the present study we evaluated the precision of the ELISA method
to quantify caffeine in human plasma and compared the results with
those obtained by gas chromatography. A total of 58 samples were
analyzed by gas chromatography using a nitrogen-phosphorus detec-
tor and routine techniques. For the ELISA test, the samples were
diluted to obtain a concentration corresponding to 50% of the absorb-
ance of the standard curve. To determine whether the proximity
between the I50 of the standard curve and that of the sample would
bring about a more precise result, the samples were divided into three
blocks according to the criterion of difference, in modulus, of the I50 of
the standard curve and of the I50 of the sample. The samples were
classified into three groups. The first was composed of 20 samples
with I50 up to 1.5 ng/ml, the second consisted of 21 samples with I50
ranging from 1.51 to 3 ng/ml, and the third of 17 samples with I50
ranging from 3.01 to 13 ng/ml. The determination coefficient (R2 =
0.999) showed that the data obtained by gas chromatography repre-
sented a reliable basis. The results obtained by ELISA were also
reliable, with an estimated Pearson correlation coefficient of 0.82
between the two methods. This coefficient for the different groups
(0.88, 0.79 and 0.49 for groups 1, 2 and 3, respectively) showed
greater reliability for the test with dilutions closer to I50.
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Caffeine is one of the most frequently
consumed substances in the world; it is pre-
sent in coffee-, chocolate- and cola-based
beverages (1). Together with theophylline
and theobromine, it belongs to the xanthine
group. The methylxanthines exert a pharma-
cological function in various systems, such
as the central nervous system, causing anxi-
ety and fear (2), stimulation of the cardiovas-
cular system, leading to tachycardia and ar-
rhythmia (3) and relaxation of the smooth
musculature (4).
Caffeine is quickly absorbed, reaching its
maximum concentration within 1 h, and is
metabolized by the liver. Its half-life is 3 to 7
h. The main metabolite is paraxanthine, which
represents 95% of the elimination form of
the substance (5).
Caffeine is employed therapeutically in
cases of asthma and chronic obstruction of
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the lungs. However, it also has toxic effects.
After ingesting approximately 15 mg/kg, a
person may show severe alterations in the
nervous and circulatory system, such as sleep-
lessness, anxiety, delirium, vomiting and
convulsions (6). Another important charac-
teristic is physical dependence, commonly
observed after daily ingestion of at least 400
mg of caffeine over a period of two weeks.
Moreover, daily ingestion of 250 mg during
a long period of time can also lead to de-
pendence (7). Migraine, fatigue, lethargy and
sleeplessness are the main symptoms which
can be observed up to 48 h after intake (8).
Physical dependence is more common
than assumed. To investigate this hypothesis,
plasma samples from patients of the Psychi-
atric Hospital of the University of Kentucky
were quantified for caffeine. The methods
usually employed to quantify caffeine in
biological specimens are gas chromatogra-
phy and high-performance liquid chroma-
tography, which are time consuming and
expensive (9). On the other hand, the ELISA
method is of easy and rapid execution and
inexpensive (10).
The objective of the present study was to
compare the results obtained with  gas chro-
matography and ELISA to determine the
precision of the latter method for caffeine
quantification. Caffeine was quantified in
64 human plasma samples originating from
the University of Kentucky Hospital. All
samples arrived frozen and were maintained
thus throughout the experiment, being thawed
only to collect the aliquot to be used. For the
gas chromatography method (11), standard
caffeine (Sigma Chemical Co., St. Louis,
MO, USA) solutions were prepared in metha-
nol (Mallinckrodt Inc., Paris, KY, USA) in
order to establish the standard curve on the
basis of five known concentrations (50, 100,
250, 500 and 1,000 ng/ml of plasma). Each
sample received 1,000 ng/ml of cyclizine
(Sigma), this being the internal control stan-
dard. The plasma samples and the standard
curve samples were placed in test tubes (100
µl/sample) in duplicate. Nine hundred mi-
croliters of deionized water, 1 ml of satu-
rated sodium solution and 2 ml of dichloro-
methane (Sigma) were added to each tube.
The samples were shaken for 4 min and
centrifuged for 1 h at 626 g and 4oC. The
organic phase was dried under a nitrogen
stream at 35oC. The samples were then re-
constituted with 50 µl of methyl alcohol,
shaken for 15 s and submitted to a gas chro-
matograph (Varian Star 3400CX - Varian
Analytical Inst., Palo Alto, CA, USA)
equipped with a nitrogen-phosphorus detec-
tor. Hydrogen at a flow of 4.7 ml/min and air
at a flow of 167 ml/min were used as the
mobile phase. The apparatus contained a 15
m x 530 µm x 1 µm polymer capillary
(Megabore DB17; J & W Scientific, Folsom,
CA, USA), which received a constant flow
of helium at the rate of 21 ml/min. The initial
temperature of the capillary was 70oC and
the final temperature 280oC.
The measurement of caffeine by ELISA
is based on a previously described method-
ology (10). Each ELISA well received 20 µl
of the sample or of the internal standard
solution and 180 µl of the drug-enzyme com-
plex diluted 1:180. The solution was lightly
mixed for 1 min and incubated at room tem-
perature for 45 min. Each well was washed
three times with 300 µl of washing buffer.
The next step consisted of the addition of
150 µl of substrate. The plate was shaken for
30 min at room temperature and absorbance
at 650 nm was measured with a microwell
reader (Bio-Tek Inst., Lake Havasu City,
AZ, USA).
The 64 samples of human plasma were
first examined using gas chromatography,
considered to be the standard method to
quantify this drug. The identification of caf-
feine and cyclizine was confirmed on the
basis of the chromatograms of the internal
standard which contained only methyl alco-
hol, caffeine and cyclizine. Only 6 of the 58
samples did not conform to the standard
curve, i.e., their concentrations were below
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50 ng/ml, which was the minimum concen-
tration of the standard curve. Thus, in these
cases the samples were disregarded for the
purpose of statistical analysis.
With the objective of developing a rapid
and economic method, we quantified the
samples again by ELISA. The standard curve
was obtained with five dilutions of 1 to 100
ng/ml of plasma. The samples were diluted
so as to show a value close to I50 (concentra-
tion which determines 50% inhibition of the
maximum absorbance obtained with the stan-
dard curve of the experiment). The average
I50 of the experiment was 7.27 ng/ml, quite
close to the I50 determined by the manufac-
turer (Neogen Corporation, Lexington, KY,
USA), of 6 ng/ml.
As can be seen in Figure 1, the methods
were compared by the Pearson correlation
coefficient (r) (12), which showed a value of
r = 0.82 (P<0.01) (SAS System). The equa-
tion that describes the curve was y = 1855.39
+ 1.02x (R2 = 0.82). To determine whether
the proximity between the I50 of the standard
curve and that of each sample would lead to
a more precise result for ELISA, the samples
were divided into three blocks according to
the criterion of sample I50 deviation from the
I50 of the standard curve (Figure 2). The first
block, consisting of 20 samples which devi-
ated from the I50 by 0 to 1.5 ng/ml, obtained
an r = 0.88 (P<0.01). The second block,
consisting of 21 samples which deviated
from the I50 by 1.51 to 3 ng/ml, showed an r
= 0.79 (P<0.01). The third block, consisting
of 17 samples which deviated from the I50 by
more than 3.0 ng/ml, showed an r = 0.49
(P<0.05).
The results obtained by gas chromatogra-
phy demonstrate that this method is good for
the quantification of the substance. This is
borne out by the determination coefficients
(R2) of the standard curves, always above
0.999, certifying the precision of the method
for extraction as well as for analysis.
The use of cyclizine as internal standard
was also advantageous, as demonstrated by
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Figure 1. Regression curve between the gas chromatography (GC) and ELISA methods
used to quantify caffeine in human plasma, in ng/ml.
Figure 2. Pearson’s correlation coefficient between the results obtained by gas chromatog-
raphy and by ELISA to determine caffeine concentration in 58 human plasma samples. The
blocks express the deviation from the standard I50 (in modulo).
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repetitiveness and acuity tests. For the former,
only one sample of known concentration
was examined 10 times. The coefficient of
variation obtained without the internal cor-
rection factor (cyclizine) was 20.81%. After
adjusting the results obtained, the value fell
to 6.3%. For the latter, 10 samples of identi-
cal and known concentrations were exam-
ined. The coefficient of variation was 13.61%
without correction and was reduced to 10%
after correction. This proves the necessity of
using cyclizine as an internal standard. An-
other important conclusion is the repetitive-
ness and acuity of the method, now also
established by these results, which were
found to be below the 15% level determined
elsewhere (13) as the maximum for a reli-
able analysis.
The ELISA proved to be adequate since
the R2 was always higher than 0.99. How-
ever, most of the concentrations obtained by
ELISA were higher than those obtained by
gas chromatography on the basis of pair
comparison. This can be explained by the
fact that the antibody of the plate allows a
cross-reaction with other methylxanthines
such as theobromine or theophylline. The
metabolites of caffeine can also modify the
intensity of the reaction.
Statistical analysis of the data shows that
the two methods present a good correlation.
Separating the samples tested by ELISA into
blocks, it was noted that variations between
the I50 of the standard curve and the I50 of the
sample above 3 ng/ml no longer represented
a reliable quantitative result. On the other
hand, we conclude that the use of ELISA to
quantify caffeine in human plasma, with
dilutions close to the I50, i.e., with a differ-
ence, in modulo, of up to 3 ng/ml, can be
considered a reliable, simple, economic and
fast option for screening analysis or even for
quantification assays. These results corrobo-
rate observations which recommend ELISA
tests for the determination of doping in horses
(14).
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